Mark Lawrence Rubinstein
CIK: 0002103809
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ACHV
ACHIEVE LIFE SCIENCES, INC.
Officer
Discretionary Trading P&L
Holdings
About Rubinstein Mark Lawrence
Rubinstein Mark Lawrence (SEC CIK 0002103809) files insider reports with the SEC as Chief Medical Officer of ACHIEVE LIFE SCIENCES, INC. (ACHV).
Signal8 holds 2 ownership filings by Rubinstein Mark Lawrence (1 Form 3, 1 Form 4), filed between Jan 12, 2026 and Jan 30, 2026. Those filings report 1 transaction, the latest on Jan 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Rubinstein Mark Lawrence's filings is in BOTHELL, WA.
Recent filings by Rubinstein Mark Lawrence
- Jan 28, 2026: Grant or award of ACHV derivative securities (Form 4, code A).
Other insiders filing for ACHIEVE LIFE SCIENCES, INC. (ACHV)
- Halladay Benjamin, Chief Financial Officer
- Stewart Richard Alistair, Director
- Sellig Thomas, Director
- Martin Christopher Nathan, Director
- Royston Aaron, Director
- Waldman Reid Alexander, Director